Immunology and Microbiology
CD3 Antigen
22%
CD59
33%
CD8
22%
Cell Mutant
22%
Cell Population
22%
Cell Surface
22%
Hematopoietic Cell
44%
Hematopoietic Stem Cell
44%
Human
22%
Immunosuppression
22%
Lymphocyte
44%
Mouse Model
22%
Natural Killer Cell
22%
Normal Human
22%
Reactive Lymphocyte
100%
Somatic Mutation
22%
Stem Cell
22%
Surface Property
22%
T Cell
44%
T Cell Receptor
22%
Keyphrases
Ablating
6%
Ablation
6%
Autoreactive Cells
6%
Autoreactive Lymphocyte
18%
Blood Disorders
6%
Bone Marrow Failure
6%
Bone Marrow Microenvironment
6%
CD1d
6%
CD3+CD8+
9%
CD59
9%
CD8+ T Lymphocytes
6%
Cell Surface
6%
Cell-to-cell
6%
Clinical Prognosis
6%
Clonal Disorder
9%
Clonal Proliferation
6%
Conditional Growth
9%
Developing Strategy
6%
Functional Properties
6%
Glycophospholipids
9%
Growth Advantage
12%
Hematopoietic Cells
12%
Hematopoietic Stem Cells
6%
Hemoglobinuria
9%
Human Subjects
6%
Immunosuppression
6%
Lymphocytes
6%
Molecular Analysis
66%
Mouse Model
6%
Mutant Cells
6%
Natural Killer Cells
6%
Normal Hematopoietic Stem Cells
6%
Normal Human
6%
Paroxysmal Nocturnal Hemoglobinuria
100%
Pathophysiology
66%
Pig-a
27%
Protective Proteins
6%
Selective Mechanism
6%
Somatic mutation
6%
Specific Intent
6%
Specific T Cells
6%
Stem Cells
6%
Structure-property Relationships
6%
Surface Markers
6%
T Cell Subpopulations
6%
T Cells
6%
Thrombosis
6%
Thrombotic Manifestations
9%
X-linked
6%
Medicine and Dentistry
Bone Marrow Failure
6%
Catheter Ablation
6%
CD8 Antigen
6%
Cell Mutant
6%
Cell Population
6%
Cell Surface
6%
Disease
6%
Glycophospholipid
9%
Hematopoietic Stem Cell
12%
Hematopoietic Stem Cell
12%
Hemoglobinuria
9%
Hemolytic
9%
Human Subject
6%
Immunosuppressive Treatment
6%
Lymphocyte
30%
Natural Killer Cell
6%
Paroxysmal Nocturnal Hemoglobinuria
100%
Pathophysiology
66%
Somatic Mutation
6%
Stem Cell
6%
Sulfhemoglobinemia
6%
T Cell
12%
T Cell Receptor
6%
Tetramer
6%
Thrombosis
6%